Tous Actualités
Suivre
Abonner Gerresheimer AG

Gerresheimer AG

Dr. Bernd Metzner to Become Chief Financial Officer of Gerresheimer AG on May 15, 2019

Germany (ots/PRNewswire)

Dr. Bernd Metzner (48) takes up the position of Chief Financial Officer of Gerresheimer AG on May 15, 2019. Dr. Metzner had been Chief Financial Officer of SDAX-listed Ströer SE & Co. KGaA since 2014.

"I very much welcome the financial expertise and years of industry experience that Dr. Bernd Metzner brings to the Management Board. Together with him and Dr. Lukas Burkhardt, we make a strong Management Board team that will drive Gerresheimer's sustainable growth forward," says Dietmar Siemssen, CEO of Gerresheimer AG.

After studying business administration in Siegen, Germany, completing his doctorate and starting his career at a law firm, Dr. Metzner held various management positions in finance at the Bayer Group between 2002 and 2011. Among other roles, he was responsible for coordinating the carve-out and initial public offering of Lanxess, and held the position of CFO at Bayer Italy as well as that of global CFO in Bayer's Pharmaceuticals Division. Before joining Ströer, he served as CFO of the global, family-owned Döhler Group from mid-2011 to mid-2014.

The Management Board of Gerresheimer AG (as of May 15, 2019):

- Dietmar Siemssen, CEO responsible among other things for the 
  Plastics & Devices and Advanced Technologies Divisions 
- Dr. Bernd Metzner, CFO 
- Dr. Lukas Burkhardt, Management Board member responsible for the 
  Primary Packaging Glass Division 
Contact
Gerresheimer AG
Klaus-Bungert-Strasse 4
40468 Düsseldorf
Germany
Jens Kurten
Group Senior Director Communications & Marketing
Phone: +49 211 6181-250
Telefax: +49 211 6181-241
E-Mail:  jens.kuerten@gerresheimer.com
Website: www.gerresheimer.com 

Plus de actualités: Gerresheimer AG
Plus de actualités: Gerresheimer AG
  • 11.10.2018 – 08:05

    Gerresheimer Increases Revenues by 8.8% and Successfully Integrates Sensile Medical

    Düsseldorf, Germany (ots/PRNewswire) - - Revenues at constant exchange rates up 8.8% in third quarter of 2018 to EUR 364.4m - Adjusted EBITDA at constant exchange rates-excluding Sensile Medical and negative effects relating to the exemption from electricity network charges-increased by EUR 1.3m in third quarter to EUR 79.5m - Integration of Sensile Medical proceeding ...

  • 14.04.2010 – 07:30

    Good start to the year for Gerresheimer

    Düsseldorf (ots) - - Group sales in the first quarter up 1.4% on like-for-like basis - Profit from operations grew by 34% to EUR 12.3m - Reiteration of guidance for the financial year 2010 Gerresheimer AG has got off to a good start in the new financial year. In the first quarter (December 2009 to February 2010), sales increased by 1.4% on a like-for-like basis and amounted to EUR 224.8m. ...